insights_auto
Why is CAMX down ၂.၅၀%?
Dive Deeperchevron_right
CAMX:STO
Camurus AB
၇၂၂.၅၀ SEK
arrow_downward
-၂.၅၀%(-၁၈.၅၀) 1D
နို ၁၀, GMT+၁ ၁၇:၂၉:၅၈ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
၇၄၁.၀၀ SEK
High
၇၄၁.၀၀ SEK
Low
၇၂၀.၀၀ SEK
Mkt. cap
ဋေ ၄.၄၉ ထ
Avg. vol.
၁.၀၇ သိန်း
Volume
၈.၃၀ သောင်း
52-wk high
၇၄၁.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၂၃
Open
၇၄၁.၀၀ SEK
High
၇၄၁.၀၀ SEK
Low
၇၂၀.၀၀ SEK
Mkt. cap
ဋေ ၄.၄၉ ထ
Avg. vol.
၁.၀၇ သိန်း
Volume
၈.၃၀ သောင်း
52-wk high
၇၄၁.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၂၃
News stories
From web sources and news partners
Eurasia Business News
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Fall on November 10, 2026; Oil and Gold Retreat
TheStreet
·
ပြီးခဲ့သည့် ၁ နာရီ
Citigroup CEO offers bold S&P 500 prediction
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Explained - Three factors why Dow Jones, Nasdaq fell on Tuesday
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB